[
    [
        {
            "time": "",
            "original_text": "医药生物行业2020年报及2021年一季报总结分析：年报景气度分化 一季报复苏回暖",
            "features": {
                "keywords": [
                    "医药生物",
                    "年报",
                    "景气度",
                    "一季报",
                    "复苏",
                    "回暖"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2020年报及2021年一季报总结分析：年报景气度分化 一季报复苏回暖",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "因可转债获转换 药明康德(02359)发行13.04万股H股",
            "features": {
                "keywords": [
                    "药明康德",
                    "可转债",
                    "H股",
                    "发行"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "因可转债获转换 药明康德(02359)发行13.04万股H股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "国内创新药企再次围攻光明顶",
            "features": {
                "keywords": [
                    "国内",
                    "创新药企",
                    "光明顶"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内创新药企再次围攻光明顶",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "药明康德现2笔大宗交易 共成交720.00万元",
            "features": {
                "keywords": [
                    "药明康德",
                    "大宗交易",
                    "成交"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明康德现2笔大宗交易 共成交720.00万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药明康德今日大宗交易成交4.80万股，成交价150.0元溢价0.0%",
            "features": {
                "keywords": [
                    "药明康德",
                    "大宗交易",
                    "成交价",
                    "溢价"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明康德今日大宗交易成交4.80万股，成交价150.0元溢价0.0%",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "【行情】港股CRO概念板块午后集体下挫，药明生物跌6.5%，泰格医药跌5.8%，康龙化成跌5.2%，药明康德跌4.2% 连续下跌",
            "features": {
                "keywords": [
                    "港股",
                    "CRO",
                    "概念板块",
                    "下挫",
                    "药明生物",
                    "泰格医药",
                    "康龙化成",
                    "药明康德"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【行情】港股CRO概念板块午后集体下挫，药明生物跌6.5%，泰格医药跌5.8%，康龙化成跌5.2%，药明康德跌4.2% 连续下跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "速递 | AI平台设计RNA疗法，1.8亿美元助力推动多款疗法进入临床开发",
            "features": {
                "keywords": [
                    "AI",
                    "RNA疗法",
                    "临床开发",
                    "1.8亿美元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "速递 | AI平台设计RNA疗法，1.8亿美元助力推动多款疗法进入临床开发",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "速递 | 超20亿美元助力小分子免疫肿瘤学平台开发，礼来达成合作",
            "features": {
                "keywords": [
                    "小分子",
                    "免疫肿瘤学",
                    "礼来",
                    "合作",
                    "20亿美元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "速递 | 超20亿美元助力小分子免疫肿瘤学平台开发，礼来达成合作",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "“宁组合”PK“茅指数” ，基金抱团重仓股曝光，谁更受欢迎？",
            "features": {
                "keywords": [
                    "宁组合",
                    "茅指数",
                    "基金",
                    "重仓股"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "“宁组合”PK“茅指数” ，基金抱团重仓股曝光，谁更受欢迎？",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "A股全线反弹，创指大涨逾5%，热门赛道资金现分歧",
            "features": {
                "keywords": [
                    "A股",
                    "反弹",
                    "创指",
                    "大涨",
                    "赛道",
                    "资金",
                    "分歧"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股全线反弹，创指大涨逾5%，热门赛道资金现分歧",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]